is the concept that myocardial stretch modulates the electrophysiological properties of the heart. 1,2 MEF appears to be an important mechanism that causes arrhythmias. Myocardial stretch causes shortening of the action potential duration, 1 and mild decreases in the action potential amplitude 3 and resting membrane potential. 4 These changes may be arrhythmogenic by facilitating a variety of mechanisms, including reentry and abnormal automaticity. Furthermore, Franz et al 3 have reported that myocardial stretch induces ventricular arrhythmias triggered by early afterdepolarizations (EADs). Also, they showed that sustained load increases the dispersion of ventricular repolarization, suggesting reentry as an another mechanism of stretch-induced arrhythmias, 5 although development of the arrhythmias was not quantified.
echano-electrical feedback phenomenon (MEF)
is the concept that myocardial stretch modulates the electrophysiological properties of the heart. 1,2 MEF appears to be an important mechanism that causes arrhythmias. Myocardial stretch causes shortening of the action potential duration, 1 and mild decreases in the action potential amplitude 3 and resting membrane potential. 4 These changes may be arrhythmogenic by facilitating a variety of mechanisms, including reentry and abnormal automaticity. Furthermore, Franz et al 3 have reported that myocardial stretch induces ventricular arrhythmias triggered by early afterdepolarizations (EADs). Also, they showed that sustained load increases the dispersion of ventricular repolarization, suggesting reentry as an another mechanism of stretch-induced arrhythmias, 5 although development of the arrhythmias was not quantified.
In the present study, we examined the temporal correlation between the dispersion of epicardial and endocardial monophasic action potential (MAP) durations with the occurrence of ventricular arrhythmias during acute pressure overloading of the left ventricle (LV) in intact canine hearts. We also examined the effects of gadolinium (Gd 3+ ), 6 a non-specific blocker of stretch-activated channels (SACs). 7, 8 
Methods

Instrumentation
Seventeen mongrel dogs weighing 12 to 20 kg were anesthetized with a single intravenous dose of 30 mg/kg sodium pentobarbital. Additional doses were given as needed to maintain anesthesia. The dogs were intubated and ventilated with room air using a constant-volume respirator (Harvard Apparatus, model 607). A fluid-filled cannula was inserted into the right femoral artery and connected to a transducer (Nihon Koden, model TP400T) to monitor arterial blood pressure. A femoral venous cannula was used to infuse normal saline at a rate of 100-200 ml/h to replace spontaneous fluid losses and to inject drugs.
After left thoracotomy and pericardotomy, the ascending aorta was dissected free at a site distal to the branching of the coronary arteries. A silk ribbon was positioned around the ascending aorta, passed through a plastic tube, and used as a noose to obtain complete occlusion and release of the aorta by tightening and releasing the ribbon.
A digital thermistor was used to monitor epicardial temperature, which was maintained between 36 and 38°C by an overhead heating lamp. Heart rate was kept constant by left atrial pacing at a cycle length slightly shorter than the individual sinus cycle length (300-400 ms).
Epicardial MAP was recorded using a hand-held pressure contact electrode probe (EP Technologies, model 200), which was positioned at the anterior wall of the left ventricle. Endocardial MAP was recorded by a catheter with silver-silver chloride electrodes (EP Technologies, model 1675) which was introduced via the left carotid artery and advanced into an anteroapical position of the left ventricle. The 2 electrode probes were located within 2 cm of each other. Signals were amplified with direct current coupled differential amplifiers at a frequency range of 0.04-500 Hz. The MAP amplitude was measured as the potential difference between phase 2 and the maximal diastolic potential during phase 4. The MAP duration at 50% and 90% repolarization (APD50, APD90) was also measured.
The segment length of the regional myocardium was measured by a sonomicrometer (Ultrasonic Dimension System, Schuessler Co) through a pair of crystals (Nihon Koden, crystal transducer ZA-79) (n=6) inserted approximately 1 cm into the area adjacent to the MAP recording site, following which the end-systolic and end-diastolic lengths (ESL; EDL) were measured. LV pressure and lead II electrocardiograms were also monitored and recorded on a digital audio tape recorder (SONY model PC-108) simultaneously with MAPs, segment length, and arterial pressure.
Experimental Protocol
Five-second occlusion of the ascending aorta (aortic clamping: AC) was repeated 3 times at 5-min intervals. In protocol I (n=10), the effects of Gd 3+ on MAP changes and arrhythmias were examined. Gd 3+ was injected into the left atrium before the second (500 mol) and third AC (2500 mol) and the data were compared with the first AC (control). The dosage of Gd 3+ was set according to the study of Ovize et al. 9 The injection of Gd 3+ was started 1 min before AC.
In protocol II (n=7), the effects of Gd 3+ in the presence of verapamil, a blocker of L-type Ca 2+ channels, were examined. Verapamil (1.5 mg, approximately 0.1 mg/kg) was injected intravenously 1 min before the second AC and Gd 3+ (2500 mol) was injected before the third AC. The data obtained were compared with the control.
Plasma Levels of Gd 3+
Plasma concentrations of Gd 3+ after injecting 2500 mol were measured by inductively coupled plasma atomic emission spectrometry (n=3). 10 
Statistical Analysis
Data are expressed as mean ± SE. Differences among mean values were determined with analysis of variance for repeated measurements. Paired t-test was used when a significant difference was seen among groups. Statistical significance was set at p<0.05.
The study complied with the "Guide for the Care and Use of Laboratory Animals" published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1985).
Results
MEF Induced by AC (Fig 1, Table 1,2)
Representative recordings are shown in Fig 1. LV pressure and segment length, ie, both EDL and ESL, were increased instantaneously with the onset of AC. Epicardial APD50 and APD90 shortened in conjunction with these mechanical changes, while endocardial APD shortened to a lesser extent. Thus, the difference between endocardial and epicardial APD increased. Following these changes, premature ventricular contractions (PVCs) developed.
Repeated AC produced similar mechanical changes, ie, there were no differences in the extent of the increases in LV systolic (LVSP), end-diastolic pressure (LVEDP), and EDL or ESL at the 5th beat after the onset of AC (Table 1) . Gd 3+ at 1 min after the administration had no effects on baseline LV pressure or APD50 and APD90 ( Table 2) .
Effects of Gd 3+ on MAP Changes
Induced by AC (Fig 2-4 ) Fig 2 (A, B) depicts the MAP changes induced by control AC and AC after pretreatment with Gd 3+ . Epicardial APD50 The epicardial and endocardial APD50 were shortened by 17 ms and 3 ms, respectively, together with the increase in LV pressure and EDL · ESL produced by AC. Thus, the difference between endocardial and epicardial APD50 was increased from 12 ms to 26 ms by AC. Also, the epicardial and endocardial APD90 were shortened by 18 ms and 8 ms, respectively, and in the same way, the difference was increased from 13 ms to 23 ms by AC. Consistent with these increases, premature ventricular contractions (PVCs) developed. *denotes PVC. Epicardial APD50 and APD90 were shortened by control AC, whereas endocardial APD50 and APD90 remained unchanged. Gd 3+ suppressed these shortenings in a dosedependent manner. (Fig 2A) and APD90 (Fig 2B) shortened instantaneously after the onset of control AC. These shortenings were eliminated after pretreatment with Gd 3+ . In contrast, endocardial APD50 (Fig 2A) and APD90 (Fig 2B) remained unchanged by control AC and AC after Gd 3+ injection. Thus, the differences between endocardial and epicardial APD50 and APD90 increased significantly after the onset of control AC (Fig 3) . Pretreatment with Gd 3+ significantly suppressed these increases.
Typical recordings are shown in Fig 4. MAPs and LV pressure (LVP) at the 5th beat after the onset of AC are superimposed on the baseline traces. Epicardial MAP shortened and endocardial MAP remained unchanged in control AC. The shortening of epicardial MAP was completely eliminated after pretreatment with 2500 mol Gd 3+ . The LV systolic pressures were comparable at the 5th beat after the onset of control AC and AC after pretreatment with Gd 3+ .
Effects of Gd 3+ on Arrhythmias
Induced by AC (Fig 5A,B) The arrhythmic ratio, ie, the ratio of PVC counts divided by total beat counts during AC is presented in Fig 5A. Pretreatment with Gd 3+ reduced this ratio significantly in a dose-related manner (0.24±0.03 during control AC, 0.14±0.03 during AC after Gd 3+ 500 mol, and 0.10±0.04 during AC after Gd 3+ 2500 mol, p<0.01).
Representative recordings demonstrating the antiarrhythmic effects of Gd 3+ are shown in Fig 5B. 
Plasma Concentration of Gadolinium
The plasma concentration of Gd 3+ during AC ranged from 1 to 4 mol/L.
Effects of Verapamil and Gd 3+ on MAP Changes and Arrhythmia Induced by AC (Fig 6)
Verapamil at 1 min after the administration had no significant effects on baseline APD50 and APD90 (APD50: 122.9±4.5 128.0±5.3; APD90: 165.6±4.5 170.6±4.9).
Pretreatment with verapamil had no effects on ACinduced shortening of epicardial APD50 and APD90, while Gd 3+ suppressed shortening in the presence of verapamil. Verapamil did not reduce the arrhythmic ratio (0.32±0.03 during control AC and 0.30±0.03 during AC after verapamil), while Gd 3+ did (0.16±0.07, p<0.05). At the 5th beat after the onset of control AC, epicardial MAP was shortened whereas endocardial MAP remained unchanged. The shortening of epicardial MAP was eliminated after pretreatment with 2500 mol Gd 3+ . The LV systolic pressures were comparable at the 5th beat after the onset of control AC and AC after pretreatment with Gd 3+ .
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Discussion
Major Findings
Acute pressure overloading of the LV produced by transient cross-clamping of the ascending aorta caused preferential shortening of epicardial MAP, thereby increasing the difference between the epicardial and endocardial MAP durations, and caused PVCs. Gd 3+ prevented an increase in the difference by suppressing the shortening of epicardial MAP, and suppressed PVCs in a dose-related manner. Verapamil had no effect on MAP shortening or PVCs, however, they were suppressed by Gd 3+ in the presence of verapamil.
Possible Role of SACs in MEF
The results of the present study suggest that activation of SACs is an important mediator of MEF and ventricular arrhythmias induced by acute pressure overloading in canine hearts in vivo.
Activation of nonselective SACs generates cationic currents, such as sodium, potassium and calcium currents. According to the Goldman-Hodgkin-Katz formula, the net reversal potentials of the SACs range between -40 mV to 0 mV. At more negative potentials than the reversal potentials, SACs generate net inward cationic currents, thereby depolarizing the resting membrane potential. In contrast, SACs generate net outward cationic currents and thus shorten the action potential duration at more positive potentials, ie, at the plateau phase. 11 Interestingly, the action potential shortening and depolarization of the resting membrane potential produced by activation of SACs are similar to those seen in MEF, [1] [2] [3] [4] suggesting a link between MEF and the activation of SACs. However, this link has not been proved. Our results support this link in canine hearts in vivo.
It has been reported that intracellular calcium is increased by the activation of SACs, 12 so there may be some linkage between SACs and L-type calcium channels. Hansen et al 13 reported that 1 mol/L of verapamil produced no demonstrable inhibition of stretch-induced arrhythmias, whereas Gd 3+ suppressed arrhythmias in isolated blood-perfused canine hearts. These results suggest that SACs differ from L-type calcium channels. Consistent with their results, in our model verapamil produced no demonstrable inhibition of MAP shortening or arrhythmias, whereas Gd 3+ suppressed these changes. Therefore, suppression by Gd 3+ is thought to be due to the blockade of SACs, and not due to the blockade of the Ltype calcium channels. The plasma concentrations of Gd 3+ ranged from 1 to 4 mol/L and these concentrations are known to inhibit SACs selectively. 6, 13 It is known that channels which allow selective permeation of anion (Cl -) in response to mechanical stimuli are also present. 14, 15 Anion channels may thus also be involved Arrhythmic ratio was defined as the ratio of PVC counts divided by total beat counts during AC. Pretreatment with Gd 3+ reduced this ratio in a dosedependent manner (Fig 5A) . Control AC produced PVCs (*). AC-induced PVCs were completely suppressed after pretreatment with 2500 mol Gd 3+ . An S indicates an artifact which accompanied atrial pacing (Fig 5B) . in MEF induced by acute pressure overloading. However, the present results suggest that such anion channels are not as important as SACs because the MAP changes and arrhythmias were almost completely inhibited by Gd 3+ .
In the present model, the epicardial and endocardial responses to the aortic clamping were different. The reason is unclear, however, there are several possible explanations. First, there may be a difference in the density of SACs between the 2 layers. Second, there may be a difference in the degree of stimuli applied to the 2 layers. It is also possible that the activation threshold may differ between the 2 layers. Previously, we observed different epicardial and endocardial responses to acute myocardial ischaemia, ie, the extent of MAP shortening and the modulatory effects of ATP-sensitive K + channel opener and blocker were greater at the epicardial layer than the endocardial layer, suggesting differences in the density or activation threshold of the ATP-sensitive K + channels between the 2 layers. 16 In the same way, we believe that SACs may be distributed more densely at the epicardium, or its activation threshold may be lower. Such differences, however, have yet to be elucidated. It is also possible that a difference in the stimulus causes differential activation of the SACs and MAP responses. It has been reported that the physiological stimulus which activates SACs is a change in tension and not pressure. 17 According to Laplace's law, the degree of tension applied to the membrane is proportional to the radius of the curvature, and thus the stimulus may be greater at the epicardium than the endocardium.
Mechanisms of Stretch-Induced Arrhythmias
The activation of SACs causes action potential shortening as well as mild decreases in the resting membrane potential and action potential amplitude. Stacy et al 4 and Hansen et al 18 reported that automatic arrhythmias were elicited when stretch-induced depolarization reached a threshold potential. Franz et al 3 reported the appearance of afterdepolarizations on epicardial MAPs during aortic clamping, which were associated with ventricular arrhythmias. These studies suggest that stretch-induced arrhythmias occur due to depolarization-induced automaticity and/or triggered activity. Also, Franz et al 5 have shown that sustained load increases the dispersion of epicardial ventricular repolarization, and suggested reentry as another mechanism of stretch-induced arrhythmias. The present results suggest that acute pressure overloading of the LV increases the spatial dispersion of epicardial and endocardial MAP durations and may cause reentrant arrhythmias because arrhythmias developed in association with the increased difference in MAP durations and were suppressed by Gd 3+ in accordance with elimination of the increase in the difference. Hansen et al studied the relationship between SACs and arrhythmia using Gd 3+ . They applied a transient volume overload at an early diastolic phase, which elicited ventricular arrhythmias, to isolated blood-perfused canine hearts. Gd 3+ at concentrations ranging from 1 to 10 mol/L suppressed these arrhythmias in a dose-dependent manner. 13 Yang and Sachs reported that 10 mol/L Gd 3+ completely suppressed the activation of SACs. 6 In our model, the plasma concentrations of Gd 3+ ranged from 1 to 4 mol/L, and we believe these concentrations selectively suppressed SACs.
Blockade of SACs as a Useful Antiarrhythmic Modality
The LV experiences stretch stimuli in patients with chronic heart failure presenting as cardiomegaly or acute myocardial infarction. In these conditions, it is likely that SACs are activated and arrhythmias may be elicited by a variety of mechanisms, as mentioned above. In addition to the data reported by Hansen et al in isolated blood-perfused canine hearts, 13 we proved the antiarrhythmic effect of Gd 3+ in canine hearts in situ. Consequently, we believe the blockade of SACs might be an effective therapy against arrhythmia which appears in dilated hearts. 19 In the clinical setting, many patients present with cardiomegaly and arrhythmias, however, there is sometimes hesitation to use conventional class I antiarrhythmic drugs because of their negative inotropic action. In this situation, antiarrhythmic therapy via the blockade of SACs might be a useful alternative. However, there are concerns about the clinical use of Gd 3+ because its LD50 is one twentieth that of the chelate form, which is used in patients to enhance magnetic resonance imaging due to the accumulation of Gd 3+ in the liver, spleen, muscle and other organs. [20] [21] [22] The chelate form does not appear to exert any antiarrhythmic action because it may not block SACs. Therefore, we may have to await the development of a safer SAC blocker to treat arrhythmias associated with left ventricular dysfunction.
